ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Role of miRNA-671-5p in Mediating Wnt/β-Catenin-Triggered Podocyte Injury

Wang, Chunhong; Liu, Jiafeng; Zhang, Xiaoyao; Chen, Qiyan; Bai, Xiaoyan; Hong, Xue; Zhou, Lili*; Liu, Youhua*南方医科大学
Frontiers in Pharmacology2022-1-17DOI: 10.3389/fphar.2021.784489
7被引10阅读
引用收藏
分享

摘要

Podocyte injury and proteinuria are the most common features of glomerular disease, which is the leading cause of end-stage renal failure. Hyperactivated Wnt/beta-catenin signaling is closely associated with podocyte injury, but the underlying mechanisms are incompletely understood. Here we show that miRNA-671-5p (miR-671-5p) plays a crucial role in mediating beta-catenin-triggered podocyte injury by targeting Wilms tumor 1 (WT1). Microarray-based expression profiling revealed that miR-671-5p was the most upregulated miRNA in podocytes after beta-catenin activation. MiR-671-5p was colocalized with beta-catenin in the glomeruli of proteinuric CKD in vivo. Bioinformatics analyses and luciferase reporter assays confirmed that miR-671-5p targeted WT1 mRNA. Overexpression of miR-671-5p mimics inhibited WT1 and impaired podocyte integrity, whereas miR-671-5p antagomir preserved the expression of WT1 and other podocyte-specific proteins under basal conditions or after beta-catenin activation. In mouse remnant kidney model, overexpression of miR-671-5p aggravated podocyte injury, worsened kidney dysfunction and exacerbated renal fibrosis after 5/6 nephrectomy. In contrast, miR-671-5p antagomir alleviated podocyte injury and attenuated proteinuria and renal fibrotic lesions after glomerular injury in vivo. These studies underscore a pivotal role of miR-671-5p in mediating WT1 depletion and podocyte injury induced by beta-catenin. Targeting miR-671-5p may serve as a new approach to prevent podocyte injury and proteinuria in proteinuric CKD.

学科与关键词

关键词
podocyte injuryWntbeta-cateninmiRNA-671-5pWT1proteinuria
相关
加载中…
  • Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis
    Zhou, Dong*; Wang, Yuanyuan; Gui, Yuan; Fu, Haiyan; Zhou, Shanshan; Wang, Yanlin; Bastacky, Sheldon I.; Stolz, Donna B.; Liu, Youhua*Kidney International, 2022, 102(1): 96-107.被引 4
  • Klotho-derived peptide 6 ameliorates diabetic kidney disease by targeting Wnt/β-catenin signaling
    Chen, Xiaowen; Tan, Huishi; Xu, Jie; Tian, Yuan; Yuan, Qian; Zuo, Yangyang; Chen, Qiyan; Hong, Xue; Fu, Haiyan; Hou, Fan Fan; Zhou, Lili*; Liu, Youhua*Kidney International, 2022, 102(3): 506-520.被引 19
  • B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-β-catenin pathway
    Li, Jiemei; Niu, Jing; Min, Wenjian; Ai, Jun; Lin, Xu; Miao, Jinhua; Zhou, Shan; Liang, Ye; Chen, Shuangqin; Ren, Qian; Shen, Kunyu; Wu, Qinyu; Li, Xiaolong; Shen, Weiwei; Hou, Fan Fan; Liu, Youhua; Yang, Peng; Zhou, LiliCell Death and Differentiation, 2022, 29(12): 2399-2416.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-01-17
卷期
第 12 卷
页码
784489
DOI
10.3389/fphar.2021.784489
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81521003, 81770715, 81920108007]

作者

  • W

    Wang, Chunhong (第一作者)

    southern med univ

  • L

    Liu, Jiafeng

    southern med univ

查看全部 8 位作者收起作者
  • Z

    Zhang, Xiaoyao

    southern med univ

  • C

    Chen, Qiyan

    southern med univ

  • B

    Bai, Xiaoyan

    southern med univ

  • H

    Hong, Xue

    southern med univ

  • Z

    Zhou, Lili (通讯)

    southern med univ

  • L

    Liu, Youhua (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417